← brief for 2026-08-13 · Slowing decline

Preventive Strategies to Reduce Sarcopenia Risk During GLP-1-Based Anti-Obesity Therapy.

Article C Peer reviewed Observational

Key takeaways

Using GLP-1 RAs for weight loss may cause muscle loss in patients at risk of sarcopenia. This review discusses strategies to support muscle health during treatment.

Who did this work

Belančić A · Skroče K · Gkrinia EMM · Marinović Glavić M · Kwok MK

Source

Article · PubMed, the drug frontier · 2026 Jul 27
https://pubmed.ncbi.nlm.nih.gov/42589975/